Education

Unveiling the Mysteries: Fascinating Facts About Rh-Negative Blood

Why Rh-negative blood matters: the 1939 stillbirth that led to its discovery, the medicine that protects babies, and the myths science rejects.

By Written Facts StaffJune 3, 2023Updated October 15, 20268 min read

You glance at a lab report, a donor card, or a prenatal chart and see a small minus sign after your blood type: O−, A−, B−, AB−. That minus means your red blood cells lack one protein, called RhD. It's less common than you might think. Roughly 7% of people worldwide share it. It is not a sign of alien ancestry, a royal bloodline, or a higher IQ. What makes it fascinating is the real history: a tragic stillbirth, a monkey-blood experiment, a medicine that protects babies, and ancient DNA from Neanderthals.

What the "negative" actually means

The Rh system is one of the most complex blood group systems in the body. It includes more than 50 antigens, which are markers on the surface of red cells. Five of them matter most in medicine: D, C, c, E, and e. When people say "Rh-positive" or "Rh-negative," they almost always mean the D antigen alone.

Two closely related genes on chromosome 1 make these markers: RHD and RHCE. In most Rh-negative people, the RHD gene is simply missing. The minus sign is not a mutation that adds something unusual. It marks a gene that isn't there.

Who has it, and where

Globally, Rh-negative blood is uncommon, at roughly 7% of people. In the United States it is about twice that, at around 15%. It is much rarer among indigenous African and Asian populations.

The standout is the Basque population of northern Spain and southwestern France. Historical surveys put Rh-negative people at 30% to 35% of the population. Modern genetic studies find the RHD deletion in about 47% of Basque gene copies. No one has a settled explanation for why it became so common there.

There is an even rarer extreme. In "Rh-null" blood, sometimes called golden blood, red cells lack every Rh antigen, not just D. It was first identified in 1961 in an Australian Aboriginal woman. Fewer than 50 people with it have been documented.

How the Rh factor was discovered

The story began with a loss. In 1939, Philip Levine and Rufus Stetson described a woman in the Journal of the American Medical Association. She had delivered a stillborn baby and then reacted badly to a blood transfusion from her husband, even though the two shared an ABO blood type. Her body had made antibodies against something inherited from the father that the existing blood groups didn't explain.

In 1940, Karl Landsteiner and Alexander Wiener reported the factor that would be named "Rh." They had injected red cells from rhesus macaques into rabbits and guinea pigs. The animals' sera then clumped about 85% of human blood samples they tested, which is close to the share of people now known to be Rh-positive. In 1946, Landsteiner, Wiener, and Levine shared a Lasker Award. They were honored for discovering the Rh factor and for explaining a deadly disease of newborns.

There is a twist. Scientists later found that the monkey-derived antibody was not the same as the human anti-D antibody. The marker it actually detected was renamed the LW antigen, after Landsteiner and Wiener. So the name "Rh" honors a monkey whose blood doesn't quite match what it was named for.

Why it matters in pregnancy

Levine's stillbirth case points to the one place where Rh status matters most. An Rh-negative mother can carry an Rh-positive baby. If some of the baby's blood reaches her bloodstream, her immune system can make anti-D antibodies. In a later pregnancy, those antibodies can attack the baby's red blood cells.

This condition is called hemolytic disease of the fetus and newborn (HDFN). Without treatment, it can cause:

severe anemia
very high bilirubin levels, which show up as jaundice
kernicterus, a form of brain damage caused by bilirubin
hydrops fetalis, a life-threatening buildup of fluid in the baby

The medicine that changed the outcome

In 1968, the U.S. Food and Drug Administration approved Rho(D) immune globulin, sold as RhoGAM. It works by preventing the mother's immune system from making anti-D in the first place.

The standard approach is a 300 mcg dose at about 26 to 28 weeks of pregnancy. A second dose follows within 72 hours of delivery if the newborn turns out to be Rh-positive. That is why your blood type is checked early in prenatal care.

Some of these injections came from one man's arm. Australian donor James Harrison, known as "the Man with the Golden Arm," had plasma rich in rare anti-D antibodies. He donated 1,173 times. Those donations helped make injections credited with saving an estimated 2.4 million babies. He died on February 17, 2025, at age 88.

The guidance keeps evolving. In late 2024, the American College of Obstetricians and Gynecologists recommended skipping routine Rh testing and immune globulin for pregnancy loss or abortion before 12 weeks. The reason is that the risk of the mother making antibodies that early is very low.

Supply has been a recent worry. Manufacturing problems put Rho(D) immune globulin on the FDA's shortage list. Distributor limits on Kedrion's RhoGAM were lifted in August 2025, and the FDA listed the shortage as resolved in January 2026.

A trait older than our species

Rh variation is not new, and it isn't uniquely modern-human. A 2021 study in PLOS ONE, led by Silvana Condemi, examined the genomes of Neanderthals and Denisovans. The researchers found that these ancient humans carried RHD and RHCE gene variants linked to hemolytic disease in newborns. One partial Rh variant they found still appears today in Aboriginal Australian and Papuan populations.

This does not mean Rh-negative blood "came from" Neanderthals. It shows that these blood group genes have varied across human lineages for a very long time. It also suggests that pregnancy problems like HDFN may have affected ancient populations too.

What the health research shows

Because the trait is uncommon, many health claims have built up around it. Few hold up.

Disease risk: Large population studies link heart disease and cancer risk mainly to ABO blood groups, especially having a type other than O. The Rh factor is not the main driver.

HIV: There is no established evidence or biological mechanism showing that Rh-negative blood protects against HIV.

Toxoplasma: One line of research is real, though narrow. Studies led by Jaroslav Flegr found that Rh-negative and Rh-positive people are infected with the parasite Toxoplasma gondii at similar rates. Among infected people, however, Rh-negative individuals showed slower reaction times and higher traffic accident rates. This is an intriguing finding about one parasite. It is not evidence that Rh-negative people are generally fragile or special.

The myths, plainly

The internet attaches much more to Rh-negative blood than science does. There is no good evidence for any of the following:

extraterrestrial origins or psychic ability
descent from European royalty, Atlantis, or Lemuria
higher IQ, lower body temperature, larger heads, or sharper senses
lighter eyes and hair, or greater sun sensitivity, caused by Rh status
distinct personality traits, such as unusual empathy or creativity
higher baseline inflammation

Lists of "famous Rh-negative people" are just as shaky. Claims about Queen Elizabeth II, Brad Pitt, Cleopatra, or Jesus rest on rumor, not medical records.

The true story needs no embellishment. A missing gene, concentrated in one corner of Europe, led to a medicine that has spared millions of babies. If your blood type carries a minus sign, the practical takeaway is simple: know it, and tell your doctor or midwife if you're pregnant.

Sources (35)